Skip to content
Peptideworth

Ranked board

Peptides sold to women: who sells them, and what the trials say

Most peptide sellers write to nobody in particular. These are the ones whose own copy addresses women — and three of the five are selling the same molecule, bremelanotide, which is the rare case here where the trials in that population genuinely exist: two completed phase 3 trials in 1,437 premenopausal women underpin an approved product. The claims are still graded as reaching past them, because what those trials measured and what the pages advertise are not the same thing.

By Grant Delaney, Research Editor

Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.

What gets on this board

Every published review with at least one product whose own name or verbatim marketing copy addresses women. Read from the seller's page, never from the brand name — one company here is two sex-segmented brands under one roof and addresses neither audience in the product copy we graded. Only the products addressed to women are counted.

What decides the order

Ranked by how much of what each company sells is described accurately — the share of the products this board counts whose marketing claim matches the trials behind it. Ties go to the company with more matching claims, then to the one that names its pharmacy, then to the one that publishes a testing regime, and last of all to alphabetical order. Nothing is pinned, sponsored, or lifted into position.

What the grading found

1/6

Claims that match the trials

Across every one of these companies' products sold to women that we have graded.

2/6

Name their pharmacy

A telehealth brand is almost never the pharmacy that fills the order.

0

Publish a readable certificate

Of every company reviewed on this site, not just those on this board.

The ranking

Every product counted here was graded against the published trials for that molecule, using the company's own words about it. The three counts below are that grading, and they are the ranking — there is no score, no weighting and no adjustment behind them.

Only the products whose own copy addresses women are counted here. A company's sex-neutral products are counted on the boards that cover them, and a product addressed to both audiences appears on this board and the men's board alike.

CompanyClaims vs. trialsDisclosesVisit
Eden

Checked August 2026

FDA letter — marketing

1/1100%

  • 0 reach past the trials
  • 0 with no trial behind them
Testing shown
Visit
Invigor Medical

Checked August 2026

0/10%

  • 1 reach past the trials
  • 0 with no trial behind them
Pharmacy namedTesting shown
Visit
PeptidesRx

Checked August 2026

0/10%

  • 1 reach past the trials
  • 0 with no trial behind them
Pharmacy namedTesting shown
Not linked
Valhalla Vitality

Checked August 2026

0/10%

  • 1 reach past the trials
  • 0 with no trial behind them
Testing shown
Visit
Defy Medical

Checked August 2026

0/10%

  • 1 reach past the trials
  • 0 with no trial behind them
Nothing published
Visit
Lighter You

Checked August 2026

0/10%

  • 1 reach past the trials
  • 0 with no trial behind them
Nothing published
Visit

How a claim is graded, and what moves a compound between evidence tiers, is on our methodology page.

What this board does not measure

Whether it works

A company can describe a weakly-evidenced product accurately and rank well here. What the evidence says about each molecule is on its own graded compound page, and the two questions are deliberately kept apart.

Clinical care

We read public pages. We have not been a patient of any of these companies, have not assessed a consultation, and publish no quality score of any kind.

Price

Prices appear on a review as a note where a company publishes one, and they are not part of this ranking. A cheaper company is not lower here and a dearer one is not higher.

Product quality

Not one company reviewed here publishes a certificate of analysis a customer can read. Until that changes, nothing on this site can tell you what is in a vial.

Considered, and not on this board

12 companies were inside this board's candidate net and did not meet its rule. Each one has a published review here, and none was left off for an unflattering result.

  • 1st Optimal

    None of 1st Optimal's 4 product pages addresses women. Its copy for Sermorelin and CJC-1295, Not named — sold only as "peptides", GLP-1 receptor agonist, molecule not named on any page that sells it is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.

  • AgelessRx

    None of AgelessRx's 6 product pages addresses women. Its copy for Rapamycin (sirolimus), Semaglutide, Sermorelin, Nicotinamide adenine dinucleotide (NAD+) and 1 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.

  • Auren Rx

    None of Auren Rx's 6 product pages addresses women. Its copy for Semaglutide, Tirzepatide, GHK-Cu, Glutathione and 2 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.

  • Hone Health

    None of Hone Health's 5 product pages addresses women. Its copy for Bremelanotide (PT-141), Sermorelin, Nicotinamide adenine dinucleotide (NAD+), Glutathione and 1 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.

  • Joi + Blokes

    None of Joi + Blokes's 5 product pages addresses women. Its copy for Tirzepatide, Semaglutide, Sermorelin, Vasoactive intestinal peptide (VIP) and 1 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.

  • Maximus

    None of Maximus's 5 product pages addresses women. Its copy for Oxytocin, Sermorelin, Tesamorelin, Semaglutide and 1 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.

  • NovoCare Pharmacy

    None of NovoCare Pharmacy's 3 product pages addresses women. Its copy for Semaglutide is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.

  • Regenics

    None of Regenics's 6 product pages addresses women. Its copy for Tesamorelin, BPC-157, Epithalon (epitalon), MOTS-c and 2 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.

  • Rehydra+ Wellness

    None of Rehydra+ Wellness's 3 product pages addresses women. Its copy for Semaglutide, Tirzepatide, Nicotinamide adenine dinucleotide (NAD+) is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.

  • The Edit Health

    None of The Edit Health's 6 product pages addresses women. Its copy for Semaglutide, Tirzepatide, GHK-Cu, Sermorelin and 2 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.

  • Trellis Vitality

    None of Trellis Vitality's 5 product pages addresses women. Its copy for Semaglutide, Tirzepatide, Tesamorelin, Nicotinamide adenine dinucleotide (NAD+) and 1 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.

  • Vyvron

    None of Vyvron's 5 product pages addresses women. Its copy for Sermorelin, Nicotinamide adenine dinucleotide (NAD+), Methylcobalamin with methionine, inositol and choline (B12-MIC), Semaglutide and 1 more is written to no particular audience, so there is no claim made to women here for us to grade — a fact about its marketing, not about who it will treat.

Frequently asked questions

Is this board claiming a compound acts differently by sex?

No, and nothing on this site does. We have no cited trial showing a sex difference for any compound here, so we make no such claim. What this board reports is narrower and entirely checkable: which companies write to women on their own product pages, and whether the claim made there survives the trials behind that molecule.

Why is a company missing when it clearly treats women?

Because it never says so on a product page. Nearly every company on this site will treat anyone its licensing allows; most of them just write copy addressed to nobody. The register below names every company that was considered and did not qualify, with what its pages actually say, so absence here is never mistaken for exclusion there.

Nothing pinned

Ranked by how much of what each company sells is described accurately — the share of the products this board counts whose marketing claim matches the trials behind it. Ties go to the company with more matching claims, then to the one that names its pharmacy, then to the one that publishes a testing regime, and last of all to alphabetical order. Nothing is pinned, sponsored, or lifted into position.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.